NFKB1 and cancer: This observation combined with the findings of others that the curcumin glucuronides (8) and (11) are ineffective as NFκB inhibitors [21] as well as very poorly cytotoxic to cancer cell lines [20,21] support the conclusion that unmodified curcuminoids are the pharmacologically active agents while their glucuronidated biotransformed products are not.